The world of drone technology has rapidly evolved in recent years, bringing cutting-edge innovation into the hands of hobbyists, professionals, and tech enthusiasts alike. Among the rising stars of ...

Skyhawk residents are pushing back against a proposal to quadruple the number of beds at a recovery center in the northeast Santa Rosa neighborhood. Pura Vida Recovery Services currently operates a ...

We all once believed that owning a drone is not something you do impulsively or without proper financial planning. It's either you go for a cheap fake drone or you go for an expensive high-quality ...

Make sure not to miss this valuable item your first time around. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Add us as a preferred source on ...

Peter earned a Bachelor of Archeology and Creative Writing from the University of Alabama and has since joined his love of driving and riding with storytelling. His voice is full of southern ...

Matt Nelson is an automotive journalist with nearly a decade of experience in all things cars. He's spent years working at dealerships in sales, finance, and service. He's since traded in his pens and ...

SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral dose Treatment with SKY-0515 also results in important dose-dependent ...

BOSTON, Sept. 17, 2025 /PRNewswire/ -- Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets, today ...

Skyhawk and Merck KGaA collaborate to discover RNA-targeting small molecules for neurological disorders using Skyhawk's SkySTAR platform. Skyhawk will focus on discovery and preclinical development, ...

Merck KGaA (XTER:MRK) is going back on offense in neurologyand it's betting big. The German drugmaker just announced a collaboration with Skyhawk Therapeutics that could top $2 billion, aimed at ...

Skyhawk Therapeutics enters into an option agreement to grant Merck exclusive global rights to drug candidates pursued under the collaboration upon option exercise Total deal value exceeds $2 billion ...

Merck KGaA agreed to collaborate with Skyhawk Therapeutics Inc. to develop neurological therapies in a deal that could be valued at more than $2 billion as the German company seeks to bolster its drug ...